Page last updated: 2024-09-05

dabigatran and Psoriasis

dabigatran has been researched along with Psoriasis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bragazzi, NL; Conic, RRZ; Damiani, G; Finelli, R; Malagoli, P; Morrone, A; Pacifico, A; Pigatto, PDM; Schrom, K1
Dickfeld, T; Goldner, R; Schleichert, R1

Other Studies

2 other study(ies) available for dabigatran and Psoriasis

ArticleYear
Dabigatran-associated Acute Generalized Exanthematous Pustulosis (AGEP) in a psoriatic patient undergoing Ixekizumab and its pathogenetic mechanism.
    Dermatologic therapy, 2019, Volume: 32, Issue:5

    Topics: Acute Generalized Exanthematous Pustulosis; Antibodies, Monoclonal, Humanized; Antithrombins; Atrial Fibrillation; Dabigatran; Dermatologic Agents; Humans; Interleukin-17; Male; Middle Aged; Psoriasis; Skin

2019
Palmoplantar pustular eruption due to dabigatran.
    Cutis, 2016, Volume: 97, Issue:5

    Topics: Aged; Antithrombins; Atrial Fibrillation; Biopsy; Dabigatran; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Eczema, Dyshidrotic; Female; Humans; Psoriasis; Skin; Skin Diseases, Eczematous; Stroke

2016